Pancreas, Insulin, and Diabetes: Physiology and Pathophysiology
The pancreas is a dual-function organ: exocrine (digestive enzymes) and endocrine (islets of Langerhans). The endocrine pancreas regulates glucose homeostasis via hormone secretion.
Islet Cell Types and Hormones
| Cell Type | Hormone | Primary Action |
|---|---|---|
| β-cells (65–80%) | Insulin | Lowers blood glucose: promotes cellular uptake (GLUT4), glycogen synthesis, lipogenesis, protein synthesis; inhibits gluconeogenesis, glycogenolysis, lipolysis |
| α-cells (15–20%) | Glucagon | Raises blood glucose: stimulates glycogenolysis, gluconeogenesis, ketogenesis |
| δ-cells (3–10%) | Somatostatin | Inhibits insulin, glucagon, growth hormone, GI secretion |
| PP cells (1–2%) | Pancreatic polypeptide | Regulates pancreatic exocrine secretion, gastric emptying, appetite |
| ε-cells (<1%) | Ghrelin | Stimulates appetite, GH release |
Insulin Secretion Dynamics
- Trigger: Glucose enters β-cell via GLUT2 → glycolysis → ↑ATP/ADP → closes KATP channels → depolarization → voltage-gated Ca²⁺ influx → insulin granule exocytosis.
- Phases: First phase (rapid, 0–10 min, stored granules); second phase (sustained, newly synthesized).
- Modulators: Incretins (GLP-1, GIP) amplify; somatostatin, sympathetic (α2-adrenergic) inhibit.
Diabetes Pathophysiology
Type 1 (Autoimmune)
T-cell mediated β-cell destruction → absolute insulin deficiency. Requires exogenous insulin. Onset typically childhood/adolescence but can occur at any age.
Type 2 (Insulin Resistance + Relative Deficiency)
Peripheral insulin resistance (muscle, liver, adipose) + progressive β-cell failure. Risk factors: genetics, obesity, sedentary lifestyle, aging, ethnicity. Initially compensated by hyperinsulinemia; later decompensation → hyperglycemia.
Other Types
- Gestational (pregnancy-induced insulin resistance)
- MODY (monogenic β-cell dysfunction)
- Pancreatogenic (Type 3c: chronic pancreatitis, cystic fibrosis, hemochromatosis)
Therapeutic Targets
Insulin replacement, sensitizers (metformin, TZDs), secretagogues (sulfonylureas, GLP-1 RAs, DPP-4 inhibitors), SGLT2 inhibitors (renal glucose excretion), amylin analogs, immunotherapy (teplizumab for T1D prevention).
Diabetes - Related Articles
- Save on Accu-Chek Supplies: Activate Your Discount Card
- Understanding High Blood Sugar: Causes, Symptoms & Management
- Managing Blood Sugar: A Guide for Type 2 Diabetes
- Understanding and Preventing Prediabetes: A Guide
- Bioelectric Therapy: Harnessing Electrical Energy for Wound Healing
- Donate a Glucose Meter: A Guide to Charitable Donation & Resources
- Pancreatic Dysfunction and Diabetes: The Critical Link
